Prone Positioning + HFOV for Severe Pediatric ARDS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different ventilation techniques and body positions can help children with severe pediatric acute respiratory distress syndrome (PARDS) breathe better and reduce ventilator time. Researchers compare prone positioning and high-frequency oscillatory ventilation (HFOV) with supine positioning and conventional mechanical ventilation (CMV) to determine the best approach. Children who have been on a ventilator with moderate to severe PARDS for less than 48 hours qualify as candidates. As an unphased trial, this study provides a unique opportunity to contribute to vital research that could enhance treatment strategies for children with PARDS.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these ventilation and positioning techniques are safe for children with severe PARDS?
Research has shown that using high-frequency oscillatory ventilation (HFOV) along with prone positioning can improve oxygen levels in babies with severe lung problems (ARDS). Importantly, this combination did not cause any serious issues in these cases. Placing patients on their stomachs alone has been proven to help with oxygen levels, although it doesn't necessarily shorten the time they need breathing support.
For those considering HFOV, studies have found that it maintains the oxygen benefits from prone positioning even when patients are turned onto their backs. Regarding safety, these treatments have been used without major side effects, making them generally safe options for managing serious breathing problems in children.12345Why are researchers excited about this trial?
Researchers are excited about the trial combining prone positioning with high-frequency oscillatory ventilation (HFOV) for severe pediatric ARDS because it offers a unique approach compared to traditional methods. Conventional treatments usually rely on supine positioning with standard mechanical ventilation. Prone positioning is believed to improve oxygenation by redistributing lung pressures and enhancing lung recruitment. Meanwhile, HFOV delivers small, rapid breaths, which can minimize lung injury. By combining these strategies, the trial aims to optimize lung function and potentially improve outcomes for children with severe ARDS.
What evidence suggests that this trial's treatments could be effective for severe pediatric ARDS?
Research has shown that lying face down, known as prone positioning, can greatly improve oxygen levels in patients with acute respiratory distress syndrome (ARDS). In this trial, some participants will receive prone positioning combined with high-frequency oscillatory ventilation (HFOV), which has helped infants breathe better after heart surgery without causing serious side effects. Other participants will receive prone positioning with conventional mechanical ventilation (CMV), which studies suggest can increase oxygen levels, though it might not reduce the time patients need the machine. Longer use of prone positioning is linked to lower death rates in ICU patients with ARDS. Overall, both prone positioning and HFOV appear promising in helping children with serious breathing issues breathe easier and recover faster.13456
Who Is on the Research Team?
Ira M. Cheifetz, MD
Principal Investigator
UH Rainbow Babies and Children's Hospital
Martha AQ Curley, RN, PhD
Principal Investigator
University of Pennsylvania
David Wypij, PhD
Principal Investigator
Boston Children's Hospital
Martin CJ Kneyber, MD, PhD
Principal Investigator
Beatrix Children's Hospital
Are You a Good Fit for This Trial?
This trial is for children with severe PARDS, intubated and ventilated for less than 48 hours. They must meet specific criteria indicating lung distress and not have conditions like intracranial bleeding, obstructive airway disease, recent facial trauma, unstable fractures, certain heart diseases or be on other trials.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to one of four groups: supine/CMV, prone/CMV, supine/HFOV, prone/HFOV, and receive positional and/or ventilation therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment, including ventilator-free days and nonpulmonary organ failure-free days
Post-PICU Discharge Monitoring
Functional status and health-related quality of life are assessed at multiple intervals post PICU discharge
What Are the Treatments Tested in This Trial?
Interventions
- Conventional Mechanical Ventilation (CMV)
- High-Frequency Oscillatory Ventilation (HFOV)
- Prone Positioning
- Supine Positioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
University Medical Center Groningen
Collaborator
University Hospitals Cleveland Medical Center
Collaborator
Boston Children's Hospital
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator